May 08, 2026 | Trump Plans to Fire FDA Commissioner Makary; Leqembi SC Delayed to August episode artwork

EPISODE · May 9, 2026 · 10 MIN

May 08, 2026 | Trump Plans to Fire FDA Commissioner Makary; Leqembi SC Delayed to August

from The Pharma Closeout | Daily Pharmaceutical & Biotech News in 15 minus · host BZ Group

FDA leadership in crisis — multiple outlets report Trump will fire Commissioner Makary after 14 turbulent months. Leqembi SC review extended three months to August 24. Bayer acquires Perfuse for $2.45B; Daiichi Sankyo takes $610M ADC manufacturing hit; Gilead targets $1B in Yeztugo sales.Visit us at www.thepharmcloseout.compharma, pharmaceutical, FDA, clinical trials, biotech, drug approvals, healthcare, pharma podcast, The Pharma Closeout, Marty Makary, Trump, Leqembi, lecanemab, Eisai, Biogen, Bayer, Perfuse Therapeutics, glaucoma, Daiichi Sankyo, ADC, Enhertu, Gilead, Yeztugo, lenacapavir, PrEP, HIV, Bizengri, zenocutuzumab, CNPV, Partner Therapeutics, Artiva, rheumatoid arthritis, Odyssey Therapeutics, IPO, Entrada, Capricor, Duchenne, DMD, Angelini, Catalyst, Argenx, Vyvgart, Novo Nordisk, Wegovy, Sarepta, Lilly, Sanofi

FDA leadership in crisis — multiple outlets report Trump will fire Commissioner Makary after 14 turbulent months. Leqembi SC review extended three months to August 24. Bayer acquires Perfuse for $2.45B; Daiichi Sankyo takes $610M ADC manufacturing hit; Gilead targets $1B in Yeztugo sales.Visit us at www.thepharmcloseout.compharma, pharmaceutical, FDA, clinical trials, biotech, drug approvals, healthcare, pharma podcast, The Pharma Closeout, Marty Makary, Trump, Leqembi, lecanemab, Eisai, Biogen, Bayer, Perfuse Therapeutics, glaucoma, Daiichi Sankyo, ADC, Enhertu, Gilead, Yeztugo, lenacapavir, PrEP, HIV, Bizengri, zenocutuzumab, CNPV, Partner Therapeutics, Artiva, rheumatoid arthritis, Odyssey Therapeutics, IPO, Entrada, Capricor, Duchenne, DMD, Angelini, Catalyst, Argenx, Vyvgart, Novo Nordisk, Wegovy, Sarepta, Lilly, Sanofi

NOW PLAYING

May 08, 2026 | Trump Plans to Fire FDA Commissioner Makary; Leqembi SC Delayed to August

0:00 10:24

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Pharma Closeout | Daily Pharmaceutical & Biotech News in 15 minus?

This episode is 10 minutes long.

When was this The Pharma Closeout | Daily Pharmaceutical & Biotech News in 15 minus episode published?

This episode was published on May 9, 2026.

What is this episode about?

FDA leadership in crisis — multiple outlets report Trump will fire Commissioner Makary after 14 turbulent months. Leqembi SC review extended three months to August 24. Bayer acquires Perfuse for $2.45B; Daiichi Sankyo takes $610M ADC manufacturing...

Can I download this The Pharma Closeout | Daily Pharmaceutical & Biotech News in 15 minus episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!